{
      "brief_title": [
            "entecavir",
            "subject",
            "chronic",
            "hepatitis",
            "b",
            "infection",
            "early",
            "access",
            "program"
      ],
      "brief_summary": [
            "purpose",
            "clinical",
            "research",
            "study",
            "provide",
            "entecavir",
            "subject",
            "chronic",
            "hepatitis",
            "b",
            "infection",
            "fail",
            "demonstrate",
            "intolerance",
            "market",
            "therapy",
            "use",
            "agent",
            "contraindicate",
            "available",
            "treatment",
            "option"
      ],
      "condition": [
            "chronic",
            "disease"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "entecavir"
      ],
      "description": [
            "tablet",
            "oral",
            "1",
            "mg",
            "daily",
            "subject",
            "achieve",
            "complete",
            "response",
            "etv",
            "approve",
            "market",
            "give",
            "country"
      ],
      "other_name": [
            "baraclude"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "hepatitis",
            "b",
            "early",
            "access",
            "program"
      ],
      "gender": [],
      "minimum_age": [
            "16",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00096811.xml"
}